Outcomes of patients with HER2-negative metastatic breast cancer after platinum- and non-platinum-based first-line chemotherapy among patients with and without pathogenic germline BRCA1/2 mutations.
William JacotAmélie LusqueCécile VicierAudrey MailliezThibault de La Motte RougeLuc CabelChristelle LevyAnne PatsourisIsabelle DesmoulinsLionel UwerJean-Christophe TheryMathieu RobainOlivier CaronOlivier TredanThomas FilleronJean-Sébastien FrenelSuzette DelalogePublished in: British journal of cancer (2022)
NCT03275311.